Patents Assigned to Artex Biopharma Inc.
  • Chromene derivatives substituted by alkoxide as inhibitors of the TCR-Nck interaction
    Patent number: 10131647
    Abstract: The present invention relates to a group of compounds of formula (I) containing a chromene nucleus: and that present the capacity to inhibit the proliferation of lymphocytes mediated by the Nck interaction with TCR, so that the present invention also relates to the use of these compounds for the treatment of diseases or conditions where said interaction triggers a complication such as transplant rejection reactions, immune or autoimmune diseases, inflammatory diseases or proliferative diseases.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: November 20, 2018
    Assignee: Artex Biopharma Inc.
    Inventors: Andrés Gagete Mateos, Julio Castro Palomino, Luc Marti Clauzel, Damiá Tormo Carulla